Invesco Ltd. Omeros Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Omeros Corp stock. As of the latest transaction made, Invesco Ltd. holds 34,401 shares of OMER stock, worth $232,206. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,401

Previous 37,472 8.2%

Holding current value

$232,206

Previous $152,000 10.53%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$3.54 - $5.47 $10,871 - $16,798	-3,071 Reduced 8.2%	34,401 $136,000
Q2 2024 Aug 13, 2024	BUY	$3.04 - $4.23 $2,441 - $3,396	803 Added 2.19%	37,472 $152,000
Q1 2024 May 14, 2024	SELL	$2.88 - $4.89 $16,476 - $27,975	-5,721 Reduced 13.5%	36,669 $126,000
Q4 2023 Feb 12, 2024	SELL	$1.08 - $3.63 $26,087 - $87,682	-24,155 Reduced 36.3%	42,390 $138,000
Q3 2023 Nov 13, 2023	BUY	$2.81 - $5.69 $94,348 - $191,047	33,576 Added 101.84%	66,545 $194,000
Q2 2023 Aug 11, 2023	BUY	$4.45 - $7.57 $146,712 - $249,575	32,969 New	32,969 $179,000
Q4 2022 Feb 13, 2023	BUY	$1.75 - $3.96 $21,234 - $48,050	12,134 New	12,134 $27,000
Q2 2022 Aug 15, 2022	SELL	$1.92 - $6.28 $51,482 - $168,391	-26,814 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.07 - $7.2 $410 - $583	-81 Reduced 0.3%	26,814 $161,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $8.54 $11,969 - $18,027	-2,111 Reduced 7.28%	26,895 $173,000
Q3 2021 Nov 15, 2021	BUY	$13.4 - $16.3 $61,345 - $74,621	4,578 Added 18.74%	29,006 $400,000
Q2 2021 Aug 17, 2021	BUY	$14.81 - $19.13 $137,466 - $177,564	9,282 Added 61.28%	24,428 $363,000
Q1 2021 May 17, 2021	BUY	$14.52 - $23.53 $42,195 - $68,378	2,906 Added 23.74%	15,146 $270,000
Q4 2020 Feb 16, 2021	BUY	$10.14 - $15.19 $124,113 - $185,925	12,240 New	12,240 $174,000

Others Institutions Holding OMER

# of Institutions

120

Shares Held

25.6M

Call Options Held

228K

Put Options Held

630K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $423M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account